Blank Bio
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An AI-native biotech using machine learning to design novel RNA therapeutics with improved properties.
Genetic DiseasesOncologyRare Diseases
Technology Platform
A machine learning platform that designs novel RNA sequences and structures for optimized stability, delivery, and therapeutic activity.
Opportunities
Potential to create best-in-class RNA therapeutics with improved profiles, enabling targeting of previously undruggable conditions.
Risk Factors
Risk that AI predictions do not translate to superior clinical performance, and dependency on continued access to high-quality biological data.
Competitive Landscape
Competes in the rapidly evolving AI-drug discovery arena and the crowded RNA therapeutics field, requiring demonstration of a clear advantage over empirical design.